dyslexia. Dyslexia and other symbolic dysfunctions, not elsewhere classified
Conditions
Interventions
Intervention 1: Intervention group:
Memantine drug, 5 mg tablets orally, half a pill every 12 hours, for three months
educational intervention, in this tutorial first prerequisite for learning skills such as concentration, visual and auditory short-term memory, immediate memory, visual perception, executive function,
Treatment - Drugs
Intervention group:
Memantine drug, 5 mg tablets orally, half a pill every 12 hours, for three months
Control group:
Placebo pill, 5 mg tablets, half a pill every 12 hours, for three months
Sponsors
Isfahan University of Medical Sciences, Faculty of medicine
Eligibility
Sex/Gender
All
Age
7 Years to 8 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age <14 years; diagnosis of dyslexia with standard test; acceptance of parcipitating in study; no any disease in which memantine is contraindicated; no any disease such as ADHD, mental retardation, stuttering and ect. Exclusion criteria: Not wanting to continue participating in the project; having special disease; the incidence of side effects related to medication.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nama dyslexia test score. Timepoint: Before the study, the first month, third month. Method of measurement: Nama dyslexia test that evaluated by the psychologist. | — |
Secondary
| Measure | Time frame |
|---|---|
| Don't have. Timepoint: not calculated. Method of measurement: not calculated. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMarzieh Salehi
Isfahan University of Medical Sciences, Faculty of medicine
Outcome results
None listed